Security Asset Management Abb Vie Inc. Transaction History

Security Asset Management

$170 Million
Q1 2023

A detailed history of Security Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Security Asset Management holds 15,242 shares of ABBV stock, worth $2.74 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

15,242

Previous 15,208 0.22%

Holding current value

$2.74 Million

Previous $2.46 Million 1.22%

% of portfolio

1.43%

Previous 1.36%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $4,916 - $5,662	34 Added 0.22%	15,242 $2.43 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $30,428 - $36,491	220 Added 1.47%	15,208 $2.46 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $29,526 - $33,864	-220 Reduced 1.45%	14,988 $2.01 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $157,437 - $200,154	1,144 Added 8.13%	15,208 $2.33 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $29,035 - $36,025	220 Added 1.59%	14,064 $2.28 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $23,634 - $29,904	-220 Reduced 1.56%	13,844 $1.87 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $23,408 - $26,571	220 Added 1.59%	14,064 $1.52 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $240,299 - $267,707	-2,284 Reduced 14.16%	13,844 $1.56 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $14,731 - $16,217	-144 Reduced 0.88%	16,128 $1.75 Million
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $211,286 - $285,258	2,625 Added 19.23%	16,272 $1.74 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $150,084 - $176,150	-1,747 Reduced 11.35%	13,647 $1.2 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $3,612 - $5,476	-56 Reduced 0.36%	15,394 $1.17 Million
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $30,879 - $39,470	-470 Reduced 2.95%	15,450 $1.12 Million
Q3 2018 Oct 26, 2018	BUY	$88.91 - $98.84 $34,674 - $38,547	390 Added 2.51%	15,920 $1.51 Million
Q1 2018 Apr 27, 2018	SELL	$92.01 - $123.21 $82,809 - $110,889	-900 Reduced 5.48%	15,530 $1.47 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $1.15 Million - $1.47 Million	16,430	16,430 $1.46 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Security Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Security Asset Management with notifications on news.

Account

Security Asset Management Abb Vie Inc. Transaction History